Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 20
235
Views
2
CrossRef citations to date
0
Altmetric
Research Article

A new alkaloid with cytotoxic activity from Fritillaria thunbergii Miq

, , , &
Pages 5297-5303 | Received 03 Feb 2021, Accepted 18 May 2021, Published online: 01 Jun 2021
 

Abstract

A new alkaloid named zhebeisine (1), together with four known compounds, eduardine (2), zhebeirine (3), isoverticine (4), and verticine (5), was isolated from the bulbs of Fritillaria thunbergii Miq. The structure of the new compound was elucidated on the basis of extensive spectroscopic methods and the in vitro biological activities of it were evaluated as well. Compound 1 features a veratramine skeleton with a rare 6/6/5/6/6/6 fused-ring system, representing the first reported veratramine-type alkaloid with a new oxazinane ring (ring-F) in Fritillaria genus. The cytotoxic activities study revealed that compound 1 inhibited the cell proliferation of HT29 and DLD1 (IC50 values of 25.1 and 48.8 µM, respectively) and also induced apoptosis of the above-mentioned two cancer cell lines.

Acknowledgements

The authors are grateful to Yinglan Zhao Group (State Key Laboratory of Biotherapy, Sichuan University, China) to support the implementation of the biological activity experiments.

Disclosure statement

The authors declare no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.